David Blum

Clinical Research & Medical Affairs Biodelivery Sciences International, Raleigh, NC, United States 
drug development, pain, other areas
"David Blum"

Biodelivery Sciences International - 2007 -
GlaxoSmithKline 2001-2007
Barrow Neurological Institute 1991-2001
UCLA Medical Center - Neuropsychiatric Institute
...fellowship 1989-1991
...residency 1986-1989
Medical College of Pennsylvania 1985-1986
UCSD School of Medicine 1981-1985
UCLA Biology 1979-1981
Caltech 1973-1977

Mean distance: 14.89 (cluster 31)


Sign in to add mentor
Jerome Engel Jr post-doc 1989-1991 UCLA
Marc R. Nuwer post-doc 1989-1991 UCLA
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mintzer S, Constantino T, Gidal B, et al. (2019) Markers of bone and lipid metabolism with eslicarbazepine acetate monotherapy. Epilepsy Research. 158: 106216
Wechsler RT, Radtke RA, Smith M, et al. (2019) Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsy. Epilepsia
Chung S, Sinha SR, Shah A, et al. (2019) Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures. Epilepsy Research. 153: 59-65
Abou-Khalil B, Klein P, Shah A, et al. (2018) Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures. Epilepsy Research. 147: 80-86
Sunkaraneni S, Ludwig EA, Passarell JA, et al. (2018) Population Pharmacokinetics and Exposure-Response Analyses of Eslicarbazepine Acetate Efficacy and Safety in Monotherapy of Partial-Onset Seizures. Journal of Clinical Pharmacology
Mintzer S, Wechsler RT, Rogin JB, et al. (2018) Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic drugs. Epilepsy Research. 141: 83-89
Pazdera L, Sperling MR, Harvey JH, et al. (2018) Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine. Epilepsia
Krauss G, Biton V, Harvey JH, et al. (2017) Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials. Epilepsy Research. 139: 1-8
Gidal BE, Mintzer S, Schwab M, et al. (2017) Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transporters. Epilepsy Research. 135: 64-70
Biton V, Rogin JB, Krauss G, et al. (2017) Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials. Epilepsy & Behavior : E&B. 72: 127-134
See more...